$POAI
Predictive Oncology Inc. Stock $poai

$poai Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000117184322002237 Filed on March 31, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$476.5K	$1.421M	$290.0K
YoY Change	64.31%	13.45%	-17.14%
Cost Of Revenue	$136.2K	$487.0K	$90.00K
YoY Change	51.36%	8.91%	-30.77%
Gross Profit	$340.3K	$933.7K	$200.0K
YoY Change	70.14%	15.97%	-9.09%
Gross Profit Margin	71.41%	65.72%	68.97%
Selling, General & Admin	$3.849M	$11.71M	$2.150M
YoY Change	79.03%	7.04%	-16.99%
% of Gross Profit	1131.2%	1253.85%	1075.0%
Research & Development		$315.9K
YoY Change		-15.26%
% of Gross Profit		33.83%
Depreciation & Amortization	$369.8K	$1.340M	$300.0K
YoY Change	23.27%	30.78%	36.36%
% of Gross Profit	108.68%	143.55%	150.0%
Operating Expenses	$4.756M	$12.02M	$2.860M
YoY Change	66.3%	6.3%	-8.04%
Operating Profit	-$4.416M	-$20.43M	-$2.660M
YoY Change	66.01%	-19.45%	-7.96%
Interest Expense	$96.02K	$164.9K	$460.0K
YoY Change	-79.13%	-94.61%
% of Operating Profit
Other Income/Expense, Net	$44.99K	-$55.10K	$2.310M
YoY Change	-98.05%	-96.51%	-229.05%
Pretax Income	-$8.418M	-$20.32M	-$11.47M
YoY Change	-26.61%	-21.5%	-15.35%
Income Tax	-$661.7K	-$661.7K
% Of Pretax Income
Net Earnings	-$7.757M	-$19.66M	-$11.47M
YoY Change	-32.38%	-24.06%	-15.35%
Net Earnings / Revenue	-1627.84%	-1383.65%	-3955.17%
Basic Earnings Per Share		-$0.36
Diluted Earnings Per Share	-$118.1K	-$358.2K	-$637.6K
COMMON SHARES
Basic Shares Outstanding	65.58M	54.88M
Diluted Shares Outstanding		54.88M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.20M	$28.20M	$680.0K
YoY Change	4047.44%	4047.44%	353.33%
Cash & Equivalents	$28.20M		$678.3K
Short-Term Investments
Other Short-Term Assets	$513.8K	$513.8K	$290.0K
YoY Change	77.17%	77.17%	81.25%
Inventory	$387.7K	$387.7K	$289.5K
Prepaid Expenses
Receivables	$354.2K	$354.2K	$256.9K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$29.46M	$29.46M	$1.514M
YoY Change	1845.42%	1850.88%	89.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.512M	$3.326M	$3.823M
YoY Change	-34.3%	-36.28%	153.53%
Goodwill	$6.858M		$2.814M
YoY Change	143.72%		-82.07%
Intangibles	$3.962M		$3.398M
YoY Change	16.6%		-6.89%
Long-Term Investments
YoY Change
Other Assets	$167.1K	$167.1K	$116.3K
YoY Change	43.7%	39.23%
Total Long-Term Assets	$14.31M	$14.31M	$11.55M
YoY Change	23.96%	23.92%	-46.49%
TOTAL ASSETS
Total Short-Term Assets	$29.46M	$29.46M	$1.514M
Total Long-Term Assets	$14.31M	$14.31M	$11.55M
Total Assets	$43.77M	$43.77M	$13.06M
YoY Change	235.14%	235.16%	-41.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.022M	$1.022M	$1.372M
YoY Change	-25.53%	-25.42%	-56.52%
Accrued Expenses	$1.263M	$1.902M	$2.588M
YoY Change	-51.21%	-40.37%	9.13%
Deferred Revenue	$187.0K		$53.03K
YoY Change	252.55%		31.31%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$0.00	$0.00	$4.430M
YoY Change	-100.0%	-100.0%	-28.7%
Total Short-Term Liabilities	$3.241M	$3.241M	$9.337M
YoY Change	-65.29%	-65.31%	-14.13%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$25.42K	$265.1K	$235.7K
YoY Change	-89.22%	-75.46%
Total Long-Term Liabilities	$25.42K	$265.1K	$235.7K
YoY Change	-89.22%	-75.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.241M	$3.241M	$9.337M
Total Long-Term Liabilities	$25.42K	$265.1K	$235.7K
Total Liabilities	$3.506M	$3.506M	$10.42M
YoY Change	-66.35%	-66.36%	-6.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$128.0M		-$108.4M
YoY Change	18.14%		31.38%
Common Stock	$656.1K		$198.0K
YoY Change	231.31%		388.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$40.27M	$40.27M	$2.643M
YoY Change
Total Liabilities & Shareholders Equity	$43.77M	$43.77M	$13.06M
YoY Change	235.14%	235.16%	-41.63%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$7.757M	-$19.66M	-$11.47M
YoY Change	-32.38%	-24.06%	-15.35%
Depreciation, Depletion And Amortization	$369.8K	$1.340M	$300.0K
YoY Change	23.27%	30.78%	36.36%
Cash From Operating Activities	-$3.744M	-$12.21M	-$2.310M
YoY Change	62.08%	-0.4%	-17.2%
INVESTING ACTIVITIES
Capital Expenditures	-$197.1K	$910.4K	-$200.0K
YoY Change	-1.45%	205.13%	1900.0%
Acquisitions		$9.590M
YoY Change
Other Investing Activities	-$9.590M	-$9.645M	$60.00K
YoY Change	-16083.68%	-5176.43%
Cash From Investing Activities	-$9.787M	-$10.61M	-$140.0K
YoY Change	6890.94%	6234.52%	1300.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$50.51M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-37.49K	$50.34M	650.0K
YoY Change	-105.77%	288.65%	-77.19%
NET CHANGE
Cash From Operating Activities	-3.744M	-$12.21M	-2.310M
Cash From Investing Activities	-9.787M	-$10.61M	-140.0K
Cash From Financing Activities	-37.49K	$50.34M	650.0K
Net Change In Cash	-13.57M	$27.52M	-1.800M
YoY Change	653.83%	5117.86%	-3700.0%
FREE CASH FLOW
Cash From Operating Activities	-$3.744M	-$12.21M	-$2.310M
Capital Expenditures	-$197.1K	$910.4K	-$200.0K
Free Cash Flow	-$3.547M	-$13.12M	-$2.110M
YoY Change	68.11%	4.49%	-24.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Inventory Net InventoryNet	387684	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	289535	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	513778	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	256878	USD
CY2021	dei	Auditor Location AuditorLocation	Minneapolis, Minnesota
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	244830	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65614597
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19804787
CY2020	us-gaap	Interest Paid Net InterestPaidNet	145831	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2018	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1	pure
CY2018	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.040	pure
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28202615	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	678332	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	354196	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	289490	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	29458273	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	1514235	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2511571	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3822700	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3962118	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3398101	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	814454	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1395351	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	167065	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	116257	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9336921	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25415	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	235705	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	239664	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	845129	USD
CY2021Q4	us-gaap	Goodwill Goodwill	6857790	USD
CY2020Q4	us-gaap	Goodwill Goodwill	2813792	USD
CY2021Q4	us-gaap	Assets Assets	43771271	USD
CY2020Q4	us-gaap	Assets Assets	13060436	USD
CY2021	poai	Impairment Of Intangible Assets Software Acquired ImpairmentOfIntangibleAssetsSoftwareAcquired	1249727	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1021774	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1372070	USD
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4431925	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1262641	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2588047	USD
CY2020	poai	Impairment Of Intangible Assets Software Acquired ImpairmentOfIntangibleAssetsSoftwareAcquired	0	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-20428631	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-25360037	USD
CY2021	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	184528	USD
CY2020	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	843440	USD
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	239631	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	129480	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	294382	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	186951	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	53028	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	639662	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	597469	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3240508	USD
CY2020	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	2427026	USD
CY2021	poai	Debt Extinguishment Costs DebtExtinguishmentCosts	-0	USD
CY2020	poai	Debt Extinguishment Costs DebtExtinguishmentCosts	1996681	USD
CY2021Q4	us-gaap	Liabilities Liabilities	3505587	USD
CY2020Q4	us-gaap	Liabilities Liabilities	10417755	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	656146	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	198048	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	167649028	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	110826949	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128040282	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-108383108	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	40265684	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2642681	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43771271	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13060436	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1420680	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1252272	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	487024	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	447192	USD
CY2021	us-gaap	Gross Profit GrossProfit	933656	USD
CY2020	us-gaap	Gross Profit GrossProfit	805080	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10932125	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10351973	USD
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2698565	USD
CY2020	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2351709	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	774530	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	584937	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2813792	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	12876498	USD
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2893548	USD
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	164902	USD
CY2020	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1765907	USD
CY2021	poai	Gain Loss On Receivable Previously Considered Uncollectable GainLossOnReceivablePreviouslyConsideredUncollectable	0	USD
CY2020	poai	Gain Loss On Receivable Previously Considered Uncollectable GainLossOnReceivablePreviouslyConsideredUncollectable	1290000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20318832	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25884397	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-661658	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-19657174	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-25884397	USD
CY2021	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0	USD
CY2020	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	554287	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19657174	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26438684	USD
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.36
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	2.21
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54876044
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11950154
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	11231318	USD
CY2020	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2322878	USD
CY2020	poai	Stock Issued During Period Value Inducement To Promissory Note Extension StockIssuedDuringPeriodValueInducementToPromissoryNoteExtension	41250	USD
CY2020	poai	Issuance Of Shares And Prefunded Warrants Pursuant To Private Placement Value IssuanceOfSharesAndPrefundedWarrantsPursuantToPrivatePlacementValue	457823	USD
CY2020	poai	Stock Issued During Period Value Inducement To Convertible Debt StockIssuedDuringPeriodValueInducementToConvertibleDebt	120000	USD
CY2020	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	1672767	USD
CY2020	poai	Adjustments To Additional Paid In Capital Repricing And Reclassification Of Warrants AdjustmentsToAdditionalPaidInCapitalRepricingAndReclassificationOfWarrants	1865953	USD
CY2020	poai	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	192150	USD
CY2020	poai	Stock Issued During Period Value Inducement To Equity Line StockIssuedDuringPeriodValueInducementToEquityLine	4891348	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1028354	USD
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	430206	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	721269	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-25884397	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2642681	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2642681	USD
CY2021	poai	Stock Issued During Period Value Accrued Interest StockIssuedDuringPeriodValueAccruedInterest	143573	USD
CY2021	poai	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	4513871	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	514011	USD
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	USD
CY2021	poai	Stock Issued During Period Value Inducement To Equity Line StockIssuedDuringPeriodValueInducementToEquityLine	675590	USD
CY2021	poai	Stock Issued During Period Value Issued For Services And Other Adjustments StockIssuedDuringPeriodValueIssuedForServicesAndOtherAdjustments	205193	USD
CY2021	poai	Adjustments To Additional Paid In Capital Vesting Expense And Option Repricing AdjustmentsToAdditionalPaidInCapitalVestingExpenseAndOptionRepricing	704412	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-19657174	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	40265684	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-19657174	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-25884397	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1340301	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1024848	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	715938	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	721269	USD
CY2021	poai	Equity Instruments Issued For Management And Consulting EquityInstrumentsIssuedForManagementAndConsulting	205193	USD
CY2020	poai	Equity Instruments Issued For Management And Consulting EquityInstrumentsIssuedForManagementAndConsulting	450901	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	244830	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1246541	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-164902	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1765907	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-661658	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	poai	Gain Loss On Note Receivable Asset Purchase Agreement GainLossOnNoteReceivableAssetPurchaseAgreement	-0	USD
CY2020	poai	Gain Loss On Note Receivable Asset Purchase Agreement GainLossOnNoteReceivableAssetPurchaseAgreement	1290000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	541867	USD
CY2021	poai	Debt Extinguishment Costs DebtExtinguishmentCosts	0	USD
CY2020	poai	Debt Extinguishment Costs DebtExtinguishmentCosts	1996681	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2813792	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	12876498	USD
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	2893548	USD
CY2020	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2021	poai	Impairment Of Intangible Assets Software Acquired ImpairmentOfIntangibleAssetsSoftwareAcquired	1249727	USD
CY2020	poai	Impairment Of Intangible Assets Software Acquired ImpairmentOfIntangibleAssetsSoftwareAcquired	0	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-5858	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-120577	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20769	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-69913	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	98149	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	94715	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	194363	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	245526	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-350296	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1688572	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-499563	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	700966	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	54548	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	12644	USD
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-85790	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	32414	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12208929	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12257732	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	9590214	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	910429	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	298379	USD
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	193321	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	51893	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	62398	USD
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	55000	USD
CY2020	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	-0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10607536	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-167456	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50523527	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4513871	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1935855	USD
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2761867	USD
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	4162744	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	1472389	USD
CY2021	poai	Payments For Penalties PaymentsForPenalties	1073470	USD
CY2020	poai	Payments For Penalties PaymentsForPenalties	247327	USD
CY2021	poai	Proceeds From Issuance Of Stock Pursuant To Equity Line ProceedsFromIssuanceOfStockPursuantToEquityLine	675590	USD
CY2020	poai	Proceeds From Issuance Of Stock Pursuant To Equity Line ProceedsFromIssuanceOfStockPursuantToEquityLine	4891348	USD
CY2021	poai	Proceeds From Issuance Or Sale Of Equity Net Of Stock Issuance Costs ProceedsFromIssuanceOrSaleOfEquityNetOfStockIssuanceCosts	0	USD
CY2020	poai	Proceeds From Issuance Or Sale Of Equity Net Of Stock Issuance Costs ProceedsFromIssuanceOrSaleOfEquityNetOfStockIssuanceCosts	5057919	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11526	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-124500	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	25416	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	50340748	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12952689	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	27524283	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	527501	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	678332	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	150831	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28202615	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	678332	USD
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	267328	USD
CY2021	poai	Warrants Issued Debt Issuance WarrantsIssuedDebtIssuance	0	USD
CY2020	poai	Warrants Issued Debt Issuance WarrantsIssuedDebtIssuance	179324	USD
CY2021	poai	Stock Issued During Period Shares Exchange Agreement StockIssuedDuringPeriodSharesExchangeAgreement	0
CY2020	poai	Stock Issued During Period Shares Exchange Agreement StockIssuedDuringPeriodSharesExchangeAgreement	2322878
CY2021	poai	Stock Issued During Period Value Exchange Agreement Accrued Interest StockIssuedDuringPeriodValueExchangeAgreementAccruedInterest	143573	USD
CY2020	poai	Stock Issued During Period Value Exchange Agreement Accrued Interest StockIssuedDuringPeriodValueExchangeAgreementAccruedInterest	0	USD
CY2021	poai	Fixed Assets Acquired For Notes Receivable And Common Stock FixedAssetsAcquiredForNotesReceivableAndCommonStock	0	USD
CY2020	poai	Fixed Assets Acquired For Notes Receivable And Common Stock FixedAssetsAcquiredForNotesReceivableAndCommonStock	2962767	USD
CY2021	poai	Increase In Operating Lease Right Of Asset And Lease Liability Due To Lease Modification IncreaseInOperatingLeaseRightOfAssetAndLeaseLiabilityDueToLeaseModification	77128	USD
CY2020	poai	Increase In Operating Lease Right Of Asset And Lease Liability Due To Lease Modification IncreaseInOperatingLeaseRightOfAssetAndLeaseLiabilityDueToLeaseModification	1417077	USD
CY2021	poai	Derivatives Debt Issued DerivativesDebtIssued	0	USD
CY2020	poai	Derivatives Debt Issued DerivativesDebtIssued	636563	USD
CY2021	poai	Inducement Shares Issued For Debt Extension InducementSharesIssuedForDebtExtension	514011	USD
CY2020	poai	Inducement Shares Issued For Debt Extension InducementSharesIssuedForDebtExtension	0	USD
CY2021	poai	Fixed Assets Acquired For Financing Arrangements FixedAssetsAcquiredForFinancingArrangements	0	USD
CY2020	poai	Fixed Assets Acquired For Financing Arrangements FixedAssetsAcquiredForFinancingArrangements	113192	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	690508	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28202615	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	0	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Accounting Policies and Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities at the date of the financial statements and during the reporting period. Actual results could materially differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Reclassifications</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain reclassifications have been made to the prior years’ financial statements to conform to the current year presentation. The reclassifications had <em style="font: inherit;">no</em> effect on previously reported results of operations, cash flows or stockholders’ equity.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2893548	USD
CY2021	poai	Impairment Of Intangible Assets Software Acquired ImpairmentOfIntangibleAssetsSoftwareAcquired	1249727	USD
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	354196	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	256878	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	186951	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	53028	USD
CY2019Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	294382	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	164902	USD
CY2021Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	129480	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	315850	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	372710	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Credit Risk </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high credit quality financial institutions and, by policy, generally limits the amount of credit exposure to any <em style="font: inherit;">one</em> financial institution. As of <em style="font: inherit;"> December 31, 2021. </em>the Company did <em style="font: inherit;">not</em> have credit risk for cash amounts held in a single institution that are in excess of amounts issued by the Federal Deposit Insurance Corporation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	193287	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	95898	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	183410	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	151366	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10987	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	42271	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	387684	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	289535	USD
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	poai	Sale Of Stock Agent Placement Fee Percent Of Gross Proceeds SaleOfStockAgentPlacementFeePercentOfGrossProceeds	0.075	pure
CY2021Q1	poai	Sale Of Stock Management Fee Percent Of Gross Proceeds SaleOfStockManagementFeePercentOfGrossProceeds	0.01	pure
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	949615
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	5.27
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y1M20D
CY2021Q4	poai	Class Of Warrant Or Right Number Of Warrants Vested And Exercisable ClassOfWarrantOrRightNumberOfWarrantsVestedAndExercisable	31725118
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	977420
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	5.29
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y9M3D
CY2020Q4	poai	Class Of Warrant Or Right Number Of Warrants Vested And Exercisable ClassOfWarrantOrRightNumberOfWarrantsVestedAndExercisable	7353376
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	146714	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	780269	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	70324	USD
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1062871
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	31699885
CY2021Q4	us-gaap	Notes Payable NotesPayable	0	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	4431925	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1062871
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	31699885
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	0	USD
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	4676755	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	244830	USD
CY2020	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	50989	USD
CY2018Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	50989	USD
CY2020	poai	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity On Exercise EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquityOnExercise	1701756	USD
CY2020	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	2669408	USD
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	1765906	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19657174	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26438684	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54876044
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11950154
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54876044
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11950154
CY2021	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	0.36
CY2020	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	2.21
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-661658	USD
CY2021Q4	poai	Valuation Allowance Percentage ValuationAllowancePercentage	1	pure
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4266955	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5434463	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-793282	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-578746	USD
CY2021	poai	Effective Income Tax Rate Reconciliation Foreign Income Tax Benefit Amount EffectiveIncomeTaxRateReconciliationForeignIncomeTaxBenefitAmount	0	USD
CY2020	poai	Effective Income Tax Rate Reconciliation Foreign Income Tax Benefit Amount EffectiveIncomeTaxRateReconciliationForeignIncomeTaxBenefitAmount	62146	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-0	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	44120	USD
CY2021	poai	Effective Income Tax Rate Reconciliation State Tax Rate Adjustment Amount EffectiveIncomeTaxRateReconciliationStateTaxRateAdjustmentAmount	-5153	USD
CY2020	poai	Effective Income Tax Rate Reconciliation State Tax Rate Adjustment Amount EffectiveIncomeTaxRateReconciliationStateTaxRateAdjustmentAmount	-65112	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	260768	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	268968	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	605420	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	2762014	USD
CY2021	poai	Effective Income Tax Rate Reconciliation State Net Operating Loss Adjustment Amount EffectiveIncomeTaxRateReconciliationStateNetOperatingLossAdjustmentAmount	-612588	USD
CY2020	poai	Effective Income Tax Rate Reconciliation State Net Operating Loss Adjustment Amount EffectiveIncomeTaxRateReconciliationStateNetOperatingLossAdjustmentAmount	-1141662	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-150083	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	461020	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3075039	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1462683	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-661658	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	295775	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	120353	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	295775	USD
CY2021Q4	poai	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	85180124	USD
CY2020Q4	poai	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	82105085	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	85180124	USD
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	7196	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	58829	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	63846	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	50537	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	162628	USD
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	26198	USD
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	11641	USD
CY2021Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	1095	USD
CY2020Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	4331	USD
CY2021Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	27859	USD
CY2020Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	63145	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	700876	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	295941	USD
CY2021Q4	poai	Deferred Tax Assets Right Of Use Assets DeferredTaxAssetsRightOfUseAssets	18543	USD
CY2020Q4	poai	Deferred Tax Assets Right Of Use Assets DeferredTaxAssetsRightOfUseAssets	13861	USD
CY2021Q4	poai	Deferred Tax Assets Nqso Compensation DeferredTaxAssetsNQSOCompensation	1602429	USD
CY2020Q4	poai	Deferred Tax Assets Nqso Compensation DeferredTaxAssetsNQSOCompensation	1738217	USD
CY2021Q4	poai	Deferred Tax Assets Operating Loss Carryforwards And Credits DeferredTaxAssetsOperatingLossCarryforwardsAndCredits	82814111	USD
CY2020Q4	poai	Deferred Tax Assets Operating Loss Carryforwards And Credits DeferredTaxAssetsOperatingLossCarryforwardsAndCredits	80038356	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	85300477	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	82400860	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	120353	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	82105085	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	374328	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	313709	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3962118	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3398101	USD
CY2021	poai	Impairment Of Intangible Assets Software Acquired ImpairmentOfIntangibleAssetsSoftwareAcquired	1249727	USD
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2997000	USD
CY2020Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	9879498	USD
CY2020Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	20976498	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7958314	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1102649	USD
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2893548	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3962118	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4126421	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	728320	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3398101	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	411609	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	411610	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	411610	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	409526	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	391610	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1926153	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3962118	USD
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2893548	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2813792	USD
CY2021Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	23790290	USD
CY2019Q4	us-gaap	Goodwill Goodwill	15690290	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	12876498	USD
CY2020Q4	us-gaap	Goodwill Goodwill	2813792	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2813792	USD
CY2021Q4	us-gaap	Goodwill Goodwill	6857790	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	595669	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	565581	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M29D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4579909	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5154547	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2068338	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1331847	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2511571	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3822700	USD
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2893548	USD
CY2021	poai	Impairment Of Intangible Assets Software Acquired ImpairmentOfIntangibleAssetsSoftwareAcquired	1249727	USD
CY2021	us-gaap	Depreciation Depreciation	965973	USD
CY2020	us-gaap	Depreciation Depreciation	711139	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M8D
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	751345	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	188931	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	71420	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	48552	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1060248	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	180922	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	879326	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1420680	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1340301	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2813792	USD
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2893548	USD
CY2021	poai	Impairment Of Intangible Assets Software Acquired ImpairmentOfIntangibleAssetsSoftwareAcquired	1249727	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-19657174	USD
CY2021Q4	us-gaap	Assets Assets	43771271	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1252272	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1024848	USD
CY2020	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	12876498	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-25884397	USD
CY2020Q4	us-gaap	Assets Assets	13060436	USD
CY2019	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1	pure
CY2019	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.040	pure
CY2021	poai	Defined Contribution Plan Employer Contribution Amount DefinedContributionPlanEmployerContributionAmount	127953	USD
CY2020	poai	Defined Contribution Plan Employer Contribution Amount DefinedContributionPlanEmployerContributionAmount	119555	USD

Files In Submission

Name	View Source	Status
0001171843-22-002237-index-headers.html	Edgar Link	pending
0001171843-22-002237-index.html	Edgar Link	pending
0001171843-22-002237.txt	Edgar Link	pending
0001171843-22-002237-xbrl.zip	Edgar Link	pending
ex_351102.htm	Edgar Link	pending
ex_351103.htm	Edgar Link	pending
ex_351104.htm	Edgar Link	pending
ex_351105.htm	Edgar Link	pending
ex_351251.htm	Edgar Link	pending
ex_352714.htm	Edgar Link	pending
ex_353039.htm	Edgar Link	pending
ex_353040.htm	Edgar Link	pending
ex_353041.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
poai-20211231.xsd	Edgar Link	pending
poai-20211231_cal.xml	Edgar Link	unprocessable
poai-20211231_def.xml	Edgar Link	unprocessable
poai-20211231_lab.xml	Edgar Link	unprocessable
poai-20211231_pre.xml	Edgar Link	unprocessable
poai20211231_10k.htm	Edgar Link	pending
poai20211231_10k_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$POAI
Predictive Oncology Inc. Stock $poai

2021 Q4 Form 10-K Financial Statement

#000117184322002237 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POAI Predictive Oncology Inc. Stock $poai

2021 Q4 Form 10-K Financial Statement

#000117184322002237 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POAI
Predictive Oncology Inc. Stock $poai